Target intelligence / Profile preview

A-form double-stranded RNA (A-form dsRNA)

Target
A-form dsRNA
Molecular classification
Nucleic acid, Pathogen-associated molecular pattern (PAMP), RNA duplex
01

Overview

A-form double-stranded RNA (dsRNA) is the primary structural conformation of duplex RNA, characterized by a deep, narrow major groove and a shallow, wide minor groove [12, 16]. It serves as a critical Pathogen-Associated Molecular Pattern (PAMP) that signals the presence of viral infection to the host's innate immune system [5, 9]. Recognition of A-form dsRNA by pattern recognition receptors (PRRs) such as Toll-like receptor 3 (TLR3), RIG-I, and MDA5 triggers the production of Type I interferons and pro-inflammatory cytokines to establish an antiviral state [3, 5, 9]. Beyond its role in immunity, the A-form geometry is essential for the mechanism of RNA interference (RNAi), where small interfering RNAs (siRNAs) adopt this conformation to be recognized by the RNA-induced silencing complex (RISC) for targeted gene silencing [8, 18]. Therapeutically, synthetic dsRNA analogues like poly I:C and rintatolimod are utilized as immunomodulators and vaccine adjuvants to enhance anti-tumor and anti-viral responses [3, 5]. However, the clinical application of dsRNA is challenged by significant safety concerns, including the potential for inducing systemic "cytokine storms" and off-target effects [3, 10, 17].

Other names
dsRNADouble-stranded RNAA-RNARNA duplexDuplex RNA
02

Mechanism of action

Agonism of pattern recognition receptors (PRRs) such as TLR3, RIG-I, and MDA5 to induce Type I interferons and pro-inflammatory cytokines; serving as a substrate for the RNA-induced silencing complex (RISC) to mediate sequence-specific mRNA degradation.

03

Biological functions

Innate immune response activationRNA interference (RNAi)Viral replication intermediateGene silencingRegulation of translation
04

Disease associations

Viral infectionCancerAutoimmune diseaseGenetic disorderInflammation
05

Safety considerations

Cytokine stormSystemic inflammatory response syndrome (SIRS)Off-target gene silencingDelivery-related toxicityImmunogenicity
06

Interacting drugs

Poly I:C (Polyinosinic-polycytidylic acid)

7 more in the full profile.

07

Biomarkers

Type I interferon (IFN-alpha/beta)Interleukin-6 (IL-6)Tumor necrosis factor-alpha (TNF-alpha)Target mRNA levelsRIG-I expression levels

Beyond the preview

Go deeper on A-form double-stranded RNA (A-form dsRNA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on A-form double-stranded RNA (A-form dsRNA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call